Global Insulin Pump Market Outlook and Forecasts Report 2023: A $6+ Billion Market by 2028 – Technological Advancements Are Revolutionizing the Insulin Delivery – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Insulin Pump Market – Global Outlook and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global insulin pump market market is projected to reach a value of $6,001.24 million by 2028 from $3,686.82 million in 2022, growing at a CAGR of 8.5% Technological Advancements Are Revolutionizing the Insulin Delivery The insulin … [Read more…]

Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Central Nervous System Partnering 2016-2023: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Central Nervous System Partnering 2016 to 2010 provides the full collection of central nervous system disease deals signed between the world’s pharmaceutical and biotechnology companies since 2016. Trends in central nervous system partnering deals … [Read more…]

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 to 2023: Featuring Abbott, Eli Lilly, GSK, Novartis & Hundreds More – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 to 2023” report has been added to ResearchAndMarkets.com’s offering. The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and … [Read more…]

Almirall, The First to Assess Wellbeing in a Dermatology Clinical Study

The protocol of the POSITIVE study, published in the British Medical Journal (BMJ)1, applies the 5-item World Health Organization Wellbeing Index, WHO-5, to capture wellbeing in moderate to severe psoriasis patients under tildrakizumab treatment in a real world setting Although almost 8 out of 10 people with psoriasis feel that the disease negatively affects their … [Read more…]

Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue

DARMSTADT, Germany–(BUSINESS WIRE)–Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the initiation of new patients on evobrutinib and patients with less than 70 days exposure to study medication in the U.S. The ongoing, fully-enrolled Phase III EVOLUTION clinical trial program … [Read more…]

Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue

DARMSTADT, Germany–(BUSINESS WIRE)–Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the initiation of new patients on evobrutinib and patients with less than 70 days exposure to study medication in the U.S. The ongoing, fully-enrolled Phase III EVOLUTION … [Read more…]

AHF responds to CDC Report of Rise in STD During Pandemic

Sexually transmitted infections — particularly syphilis and congenital syphilis—escalated during COVID-19 despite lockdowns and stay-at-home orders LOS ANGELES–(BUSINESS WIRE)–In response to just-released 2021 Centers for Disease Control (CDC) data showing sexually-transmitted-infections (STIs) increased during the COVID-19 pandemic, AHF issued the following statement: “To see almost 200 stillbirths because of congenital syphilis in the U.S.in 2021 … [Read more…]

CANbridge Pharmaceuticals Spinal Muscular Atrophy Gene Therapy Abstract Accepted for Presentation at the American Society for Gene and Cell Therapy annual Meeting

BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (1228.HK), a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of transformative therapies to treat rare diseases and oncology, announced that the American Society for Gene and Cell Therapy (ASGCT) has accepted the following abstract for presentation at the ASCGT Annual Meeting, May … [Read more…]

AHF: Pandemic Treaty Deadlock Is Not an Option

LOS ANGELES–(BUSINESS WIRE)–#COVID19–While pandemic treaty negotiations are happening largely behind closed doors, details have emerged indicating there are significant disagreements on specific provisions of the text. AIDS Healthcare Foundation (AHF) urges negotiating countries to avoid deadlock and keep the overarching objective at the forefront – the world must find a way to collaborate and ensure … [Read more…]

Patient Safety Movement Foundation Opens Registration for their 10th Annual World Patient Safety, Science and Technology Summit on June 1-2, 2023

IRVINE, Calif.–(BUSINESS WIRE)–#patientsafety–The Patient Safety Movement Foundation celebrates their 10th anniversary with an in-person summit that brings together world renowned experts to discuss today’s challenges and solutions in patient safety. The World Patient Safety, Science and Technology Summit will be held in Newport Beach, California on June 1-2, 2023. “This is our first in-person Summit … [Read more…]